End-of-day quote
NSE India S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
1,805
INR
+1.89%
+3.76%
+7.56%
Metropolis Healthcare : Resignation
August 18, 2022 at 08:24 am EDT
Ref: MHL/ ec&Legal/2022-23/56
Date: Augu t 18, 2022
To,
Li ting Compliance Department
Head, Li ting Compliance Department
Head
B E Limited
ational
tock E change of India Limited
Phiroze J ejeebhoy Towers Dalal
treet,
Exchang
Pl az a Plot No. C/l. G Block
Mumbai - 400 00 I.
Sandra -Kurla Comple , Sandra (East).
umbai- 400051.
Scrip Code: 542650
crip ymbol: METROPOLI
ub: Revi ed Intimation of Re. ignation of Mr. Vijender Singh,
EO of the Company
Dear Sir / Mad am.
This is the continuation of our I
tt r dated July 29. 2022 bearing r f e re nce No. MHL/Sec&Legal/2022-
2 3/ 41 wherein the Company has intimated that Mr. Yijend
r Singh has resigned from the position of hief
ecuti e Officer("
0 ) of
etropolis Healthcare
imited and hi
last working day with the Compan
till the closure of busine s hour
y
r 30, 2022.
of Wednesda . ovemb
Pursuant to the r equ e t recei ed
from Mr. Yij ender
ingh and al o considering the completion of his
hando e r/ t ra ns ition formalitie
the Company has agreed to release him from the position of CEO of the
Company & any other office or appointment
held by him with effect from the closing of bu s i n e ss hours of
Wednesday. August
17. 2022 and to waive his balance notice period.
Further, the Company has appoint
d a Talent
earch Agen
y and has b gun the process of finding a suitable
candidate for the position of CE
Kindl
take the same on record.
Thanking You,
Yours Faithfully,
q Por Metropolis_; Healthcare Limitedb
q')
immi ingh Bisbt
Head - Legal and cretarial Member hip No. A23360
BLOOD TESTS • DIAGNOSTICS • WELLNESS
Metropolis Healthcare Limited
Registered & Corporate Office: 250 o : ud yog Bhavan, Hind Cycle Marg, Wor li , Mumbai - 400 030.
C IN ; L73 100M H2000PLC 1927 98 Tel No.: 8422 801 801 Email: s up port @met roool isi ndla. co m
We bsit e : wv.,w_metr9p9lisindi�1-c.om
Global Reference Labora t o ry ; 4th flooI, Commffli.11 Bu,lding-1.A, KoltlnoorMall, V"td • ' h •r VI, mbll -400070.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Metropolis Healthcare Ltd. published this content on 18 August 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 18 August 2022 12:23:04 UTC .
Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue
Apr. 10
MT
Metropolis Healthcare Limited Announces Consolidated Revenue Results for the Fourth Quarter Ended March 31, 2024
Apr. 10
CI
Metropolis Healthcare's Consolidated Net Profit Declines in Fiscal Q3
Feb. 05
MT
Transcript : Metropolis Healthcare Limited, Q3 2024 Earnings Call, Feb 05, 2024
Feb. 04
Metropolis Healthcare Limited Announces Management Changes
Feb. 02
CI
Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Feb. 02
CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests
Feb. 01
RE
Transcript : Metropolis Healthcare Limited, Q2 2024 Earnings Call, Nov 06, 2023
Nov. 05
Metropolis Healthcare Limited Approves and Declares Payment of an Interim Dividend for the Financial Year 2023-24
Nov. 04
CI
Crisil Keeps AA- Rating on Metropolis Healthcare's Bank Loans; Revises Outlook to Stable
23-10-05
MT
Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023
23-09-06
CI
Metropolis Healthcare Limited Appoints Mohan Menon as Chief Marketing Officer
23-08-07
CI
Metropolis Healthcare's Consolidated Profit Drops in Fiscal Q1
23-08-04
MT
Metropolis Healthcare to Seek Smaller Bolt-On Acquisitions
23-08-02
CI
Transcript : Metropolis Healthcare Limited, Q1 2024 Earnings Call, Aug 03, 2023
23-08-02
Metropolis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
23-08-02
CI
Metropolis Healthcare Limited Appoints Neha Shah as Interim Company Secretary
23-06-20
CI
Metropolis Healthcare Seeks Acquisitions
23-05-16
CI
Transcript : Metropolis Healthcare Limited, Q4 2023 Earnings Call, May 17, 2023
23-05-16
Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
23-05-16
CI
India's Dr. Lal PathLabs reports decline in Q4 profit
23-05-11
RE
Metropolis Healthcare Limited Approves Reconstitution of Board Committees
23-04-01
CI
Metropolis Healthcare's Consolidated Profit Slides in Fiscal Q3; EPS, Revenue Miss Estimate
23-02-13
MT
Transcript : Metropolis Healthcare Limited, Q3 2023 Earnings Call, Feb 13, 2023
23-02-12
Metropolis Healthcare Limited Declares Interim Dividend for the Financial Year 2022-23
23-02-10
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
More about the company
Last Close Price
1,805
INR
Average target price
1,689
INR
Spread / Average Target
-6.41%
Consensus
1st Jan change
Capi.
+7.56% 1.11B -17.89% 8.25B +39.20% 3.58B -39.11% 2.46B -8.06% 2.46B -7.35% 2.38B -19.01% 1.55B -40.66% 1.21B -15.34% 1.03B -16.56% 878M
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1